Trials / Unknown
UnknownNCT04792112
Navigating the Grey Zone for Antenatal Corticosteroids
Improving Clinical Practice Guidelines for Antenatal Corticosteroids: Incorporating a Decision Support Tool to Tackle the Uncertain Balance of Harms and Benefits
- Status
- Unknown
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 460 (estimated)
- Sponsor
- University of British Columbia · Academic / Other
- Sex
- Female
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
The purpose of this study is to find out if including a decision support tool in clinical practice guidelines will improve how doctors discuss the option of antenatal corticosteroid treatment with patients who might deliver at 34 to 36 weeks of pregnancy.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| BEHAVIORAL | Decision support tool | Decision support tool for late preterm antenatal corticosteroids |
Timeline
- Start date
- 2022-05-20
- Primary completion
- 2024-02-01
- Completion
- 2024-02-01
- First posted
- 2021-03-10
- Last updated
- 2022-06-02
Locations
2 sites across 1 country: Canada
Source: ClinicalTrials.gov record NCT04792112. Inclusion in this directory is not an endorsement.